Showing results (11-20 of 19,542) with videos related to

Sort By:
Pageof 1,955
BMC Cancer|July 1, 2022
Genetic analysis of Japanese patients with small bowel adenocarcinoma using next-generation sequencingAtsushi Tatsuguchi, Takeshi Yamada, Koji Ueda, et al.
BMC Cancer|May 6, 2022
Maintenance Therapy with Aromatase Inhibitor in epithelial Ovarian Cancer (MATAO): study protocol of a randomized double-blinded placebo-controlled multi-center phase III TrialPamela M J McLaughlin, Maximilian Klar, Tibor A Zwimpfer, et al.
BMC Cancer|May 6, 2022
Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the "My Personal Breast Screening" (MyPeBS) randomised clinical trialAlexandra Roux, Rachel Cholerton, Jonathan Sicsic, et al.
BMC Cancer|May 6, 2022
Three-arm phase II trial comparing camrelizumab plus chemotherapy versus camrelizumab plus chemoradiation versus chemoradiation as preoperative treatment for locally advanced esophageal squamous cell carcinoma (NICE-2 Study)Yang Yang, Li Zhu, Yan Cheng, et al.
BMC Cancer|May 6, 2022
Gestational trophoblastic neoplasia with extrauterine metastasis but lacked uterine primary lesions: a single center experience and literature reviewJingnan Li, Yu Wang, Bingjian Lu, et al.
BMC Cancer|May 6, 2022
A novel and sensitive DNA methylation marker for the urine-based liquid biopsies to detect bladder cancerLeihong Deng, Haichao Chao, Huanhuan Deng, et al.
BMC Cancer|May 7, 2022
A prospective observational cohort study of lenvatinib as initial treatment in patients with BCLC-defined stage B hepatocellular carcinomaSatoshi Kobayashi, Taito Fukushima, Makoto Ueno, et al.
BMC Cancer|May 7, 2022
Efficacy of first-line treatments in the elderly and non-elderly patients with advanced epidermal growth factor receptor mutated, non-small cell lung cancer: a network meta-analysisZiyi Xu, Chengcheng Liu, Yixiang Zhu, et al.
BMC Cancer|November 24, 2022
Co-designed weight management intervention for women recovering from oestrogen-receptor positive breast cancerJ M Saxton, K Pickering, S Wane, et al.
BMC Cancer|December 12, 2022
SPARKLE: a new spark in treating oligorecurrent prostate cancer: adding systemic treatment to stereotactic body radiotherapy or metastasectomy: key to long-lasting event-free survival?Kato Rans, Berghen Charlien, Ameye Filip, et al.
Pageof 1,955